Clinical Trials Directory

Trials / Sponsors / AryoGen Pharmed Co.

AryoGen Pharmed Co.

Industry · 12 registered clinical trials.

StatusTrialPhaseStarted
CompletedrFVIII-Fc (Produced by AryoGen Pharmed Co.) Pharmacokinetic Study
Severe Hemophilia A
Phase 32023-07-22
CompletedVedAryo® (Vedolizumab) Effectiveness and Safety Evaluation
Ulcerative Colitis (UC), Crohn Disease (CD), Inflammatory Bowel Disease (IBD)
—2023-07-16
CompletedStudy on the Dose-response Relationship of Pharmacodynamic Parameters in Patients With Hemophilia With Inhibit
Hemophilia A With Inhibitor, Hemophilia B With Inhibitor
EARLY_Phase 12020-12-29
CompletedClinical Trial Comparing a Biosimilar Eptacog Alfa With Novoseven, in Patients With Hemophilia With Inhibitors
Hemophilia A or B With Inhibitor
Phase 32018-07-23
UnknownComparing Efficacy and Safety of AryoGen Pharmed Biosimilar Denosumab 60 mg (Arylia) Versus Prolia® in Improve
Osteoporosis
Phase 32017-04-29
CompletedStudy Comparing the Pharmacokinetic of Biosimilar Eptacog Alfa With Novoseven®, in Patients With Congenital Fa
Factor VII Deficiency
Phase 32017-03-01
CompletedAryoTrust® (Trastuzumab) Safety Study
Breast Cancer
—2017-02-22
CompletedPharmacokinetic, Safety and Tolerability Study of Altebrel in Healthy Male Subjects
Phase 1, Bioequivalence
Phase 12016-12-04
CompletedComparing Efficacy and Safety of Stivant (AryoGen Bevacizumab) Versus Avastin in Metastatic Colorectal Cancer
Metastatic Colorectal Cancer
Phase 32016-10-04
CompletedComparing Efficacy and Safety of AryoGen Pharmed Biosimilar Trastuzumab (AryoTrust) Versus Herceptin® in Breas
Malignant Neoplasm of Breast
Phase 32016-07-09
CompletedProspective, Non-interventional Study to Evaluate Immunogenicity of AryoSeven
Hemophilia A With Inhibitor, Hemophilia B With Inhibitor, Factor VII Deficiency
—2016-06-13
CompletedAssessment of Treatment Safety and Quality of Life in Patients Receiving Etanercept Biosimilar for Autoimmune
Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis
—2014-04-04